[2:27 pm, 01/09/2026] cm: Sign of the day
FLESCH TEST
OCCIPUT - TO - WALL TEST
Simple clinical measurement used to check for abnormal forward rounding of the upper back , known as Thoracic hyperkyphosis or poor cervical mobility like in ANKYLOSING SPONDYLITIS.
Method
Ask the Pt to stand upright with their back against a flat wall
Position of the body- Heel, calves, buttocks & shoulders touch the wall.
Pt is asked to look straight ahead with their head level in a neutral position
Pt is asked to touch the occiput directly to the wall without tilting their chin up.
A distance of 5 cms to 6.5 cms (occiput to wall) more strongly correlate with severe hyperkyphosis like ANKYLOSING SPONDYLITIS
Occiput wall distance ( OWD) has shown to have sensitivity of 92.31% , specificity 76.47% to quantify kyphotic posture of the upper thoracic & cervical spine.
This posture results in anterior displacement of the centre of gravity & is supported by compensatory widening of the base of the support & lumber hyperlordosis making the pt more prone for falls.
Dr. Prabhakar K
Prof of Medicine
SDUMC, Kolar.
πThe Narketpally sign was a test with a human name earlier!
[2:31 pm, 01/09/2026] cm: Gemini doesn't seem to know about this test!π
The term "Flesch test" in relation to ankylosing spondylitis usually refers to readability formulas like the Flesch Reading Ease Score used in medical research to evaluate how easy online health articles are for patients to understand. There is no diagnostic "Flesch test" physical exam or blood test for ankylosing spondylitis (AS). [1]
How Doctors Diagnose Ankylosing Spondylitis
Doctors use a mix of clinical evaluations, blood work, and imaging tests rather than a single test:
* Physical and spinal tests: Doctors use specific movement checks like the Schober's Test to measure lower back flexibility and range of motion.
* Imaging studies: X-rays and MRIs look for inflammation and joint damage in the spine and sacroiliac joints.
* Blood tests: Labs check for inflammation markers like C-reactive protein (CRP) and the HLA-B27 genetic marker. [2, 3, 4, 5, 6, 7]
Readability in Health Education
* Medical researchers use the Flesch-Kincaid and Flesch Reading Ease metrics to check if patient guides on sites like the Mayo Clinic are written at a level that patients can easily comprehend.
* Explore a study on chatbot readability using these indices from PMC .
* View online material metrics in the study from ScienceDirect. [1, 8, 9]
[3] https://www.niams.nih.gov/health-topics/ankylosing-spondylitis/diagnosis-treatment-and-steps-to-take
[2:33 pm, 01/09/2026] cm: Okay Gemini appears to be picky about missing an "e" at the end!π
The Occiput to Wall Distance, also called the Flesche test, measures the severity of forward spinal curvature and loss of cervical spine mobility in patients with Ankylosing Spondylitis. [1, 2]
How to Perform the Test
* Stand straight with your back against a flat wall.
* Keep your heels, calves, buttocks, and shoulders touching the wall.
* Look straight ahead with your head level.
* Try to move the back of your head (the occiput) back to touch the wall without tilting your chin up. [1, 3, 4]
Scoring and Measurement
* Normal result: The back of the head touches the wall easily, making the distance 0 cm.
* Abnormal result: The head cannot reach the wall due to tight neck joints or a forward-bending curve in the upper back (thoracic kyphosis).
* Measurement: A helper uses a tape measure or ruler to find the gap between the wall and your occiput.
* Clinical meaning: Higher numbers show worsening spinal posture and stiffness over time. [1, 2, 3, 4, 5]
Further Exploration
* Review a clinical breakdown on the Physiopedia entry.
* Read validity research in ScienceDirect . [1, 6]
[8.52 am, 02/09/2026] cm: CPC Clinical Handout (02/09/2026) Name: Mr. JS Unit Internal Medicine-E M OPD Age/Sex 54 years / Male Clinician in charge Prof. H S Kohli CR No. 202601865758/ 202601811781 Clinical discussant Dr. Karthik V M UHID 132936 Pathology discussant Prof. Uma Nahar Residence Chandigarh Radiology Discussant Dr. Vikas Bhatia Occupation Police Constable PET radiology discussant Dr. Rajinder Singh Date of admission 13/03/26 Cytology Discussant Dr. Parikshaa Gupta Date/time of death 15/03/26 Hospital stay 2 days Chief Complaints Swelling in neck X 1 month Altered mental status X 1 day HOPI The patient was apparently alright 1 month ago, when noticed swelling in the neck on both sides. Insidious onset and gradually progressing over next 2-3 weeks. Was admitted outside (Records NA) was told to have thrombocytopenia and liver lesions. He underwent a PET-CT followed by a FNAC of the cervical LN on an OPD basis from PGIMER on 12/03/26. The next morning patient was found to be in altered mental status with Lt upper limb weakness, facial deviation and dysarthria. He was admitted to the EMOPD on 13/03/26. No history of fever/ seizures/ tongue bite/ headache Past history: Seizures X 10 years on Levetiracetam 1500mg/day, Hypertension + Personal history: Alcohol ++ Family h/o: NA O/E BP- 199/115 mmHg, Spo2 : 96% on RA, Neck Rigidity +, RS : NAD, CVS/ PA : NAD E4V2M5 (Right gaze preference +). Pupils equal and reacting, Motor Power , Reflexes 2+, Plantars : NA Rt Lt Upper limbs >3/5 2/5 Lower limbs >3/5 >3/5 Investigations (Previous and Present) 13/03/2026 – Hemogram Biochemistry CSF w/u PT/INR/aPTT/ PTI – 18/1.57/33.1/63% Investigation Result Hemoglobin (g/dL) 12.6 Hematocrit / PCV (%) 38.2 RBC count (×10¹²/L) 4.16 MCV (fL) 92.1 MCH (pg) 30.4 MCHC (g/dL) 33.0 RDW-CV (%) 16.5 Platelet count (×10⁹/L) 132 Total leucocyte count (×10⁹/L) 8.9 Neutrophils (%)/ ANC 90.8 Lymphocytes (%)/ ALC 6.1/ 542 Eosinophils (%) 0.0 Monocytes (%)?AMC 13.0/1118 Basophils (%) 0.1 Peripheral smear / comments Not done ALC/ANC Investigation Result Calcium 10.4 mg/dL Amylase 69.0 U/L Sodium/ Potassium/ Chloride 124.9 mmol/L/ 4.31 mmol/L/ 93.6 mmol/L Urea Creatinine 45.5 mg/dL/ 0.859 mg/dL Total protein Albumin 8.51 g/dL/ 3.22 g/dL Bilirubin (total) 1.29 mg/dL AST 217 U/L ALT 129 U/L Bilirubin (conjugated) 0.696 mg/dL Investigation Result Protein CSF 178 mg/ dL Glucose CSF 14.0 mg/ dL Total cells 787 cells DC N 59/ L 41 PET-CT (02/03/2026- Outside): Multiple discrete/confluent intensely FDG avid (SUVmax: 19.77) bilateral level Ib, level II, level III, right level IV and level V cervical lymph nodes are noted, largest on the right side measuring approximately 5.6 x 4.0 cm Multiple discrete/confluent FDG avid (SUVmax: 10.6) right supraclavicular, right axillary and right retropectoral lymph nodes are noted, largest in the right axillary region measuring approximately 3.7 x 1.8 cm Liver measures within normal limits and reveals a lobulated outline and prominent caudate lobe – suggestive of cirrhotic changes. Multiple non-hypermetabolic enhancing lesions within the hepatic parenchyma, largest in segment V of liver measuring approximately 3.9 x 4.3 cm. Few sub-centimeter FDG avid (SUV suggestive 4.2) coeliac axis, periportal, precaval and aortocaval lymph nodes are noted – suspicious of involvement. NCCT Head: Normal study ECG: Sinus tachycardia, LVH RBS: 125mg/dL, BP recordings: 190/110- 130/90 mmHg ABG/ VBG (13/03/26): pH-7.43 PO2: 21.5, PCO2: 30.4 cHCO3: 20.1 Cervical LN FNAC (14/03/26) (Cr No.202601811781): S/o Metastatic carcinoma (CK-7 patchy positivity) FNAC CBNAAT: Negative 14/03/2026 – Blood Culture X negative 17/03/2026 – Final Fungal Culture – Negative Course and Management This 54-year-old male with prior h/o seizures and alcohol use disorder, presented with progressive cervical Lymphadenopathy. Underwent a FNAC from the L.N followed by acute onset altered sensorium with left fasciobrachial weakness and dysarthria on waking up the next morning. On evaluation, a possibility of Metastatic HCC/ Lymphoma with infiltrative meningitis Vs breakthrough seizures was kept. He was managed with IV levetiracetam and IV antibiotics (Ceftriaxone and vancomycin) , IV thiamine supplements. During this admission his general condition continued to deteriorate and was intubated on 14/03/26. He was given multiple doses of IV tranexamic acid (? indication), and his BP continuously dropped, on 15/03/26 which was nonresponsive to fluids and inotropes. He suffered a cardiac arrest and was not revived despite adequate CPR. Unit’s Final Diagnosis Metastatic Hepatocellular carcinoma ? Carcinomatous meningitis Septic Shock Cause of Death Septic shock
[8:53 am, 02/09/2026] cm: π@PaJR Health what's your prediction for today's CPC autopsy findings?
[8:54 am, 02/09/2026] PaJR Health: MOST LIKELY AUTOPSY INTERPRETATION
My leading prediction is disseminated poorly differentiated carcinoma of uncertain primary, presenting predominantly with bulky nodal disease and hepatic deposits, complicated by leptomeningeal involvement or acute meningoencephalitic illness, coagulopathy and terminal shock.
I would be cautious about accepting “metastatic hepatocellular carcinoma” as established before histology and immunohistochemistry. The liver lesions were described as non-hypermetabolic, while the nodal disease was intensely FDG-avid. Patchy CK7 positivity in a cervical-node aspirate is not specific for HCC and should prompt a broader carcinoma-of-unknown-primary work-up.
PREDICTED FINDINGS, IN ORDER OF LIKELIHOOD
1. Lymph nodes
- Extensive bilateral cervical, supraclavicular, axillary and abdominal lymphadenopathy.
- Histology showing metastatic poorly differentiated carcinoma, possibly with necrosis.
- The final tumour phenotype may be difficult to classify on morphology alone.
- I would expect confirmation with a panel including pancytokeratin, CK7, CK20, HepPar-1, arginase-1, glypican-3, TTF-1, PAX8, GATA3, CDX2 and neuroendocrine markers, according to morphology.
A lymphoma remains an important alternative if the FNAC interpretation proves misleading, particularly because widespread FDG-avid nodes can be intensely avid in both lymphoma and metastatic carcinoma.
2. Liver
- Cirrhotic or advanced fibrosis-like background related to alcohol use.
- Multiple tumour deposits or infiltrative metastatic lesions.
- Possible intrahepatic primary remains open, but I would not assume HCC solely from “liver lesions.”
- If the tumour is truly HCC, I would expect trabecular/pseudoglandular architecture and hepatocellular markers rather than merely patchy CK7 expression.
- An alternative would be cholangiocarcinoma, combined hepatocellular–cholangiocarcinoma, upper gastrointestinal/pancreatobiliary adenocarcinoma or another CK7-positive carcinoma metastatic to liver and nodes.
3. Central nervous system
The CSF is a major clue: very low glucose, high protein and 787 cells with a mixed neutrophilic/lymphocytic response. I would predict one of two principal findings:
More likely: leptomeningeal metastatic disease or malignant meningitis, possibly with tumour cells in the meninges and perivascular spaces.
Important competing possibility: acute bacterial or fungal meningitis/meningoencephalitis, with cultures rendered negative by prior antimicrobial therapy.
The sudden left-sided weakness, facial deviation, dysarthria and right-gaze preference could result from:
- Leptomeningeal tumour involvement.
- A small infarct or haemorrhage not detected on the initial noncontrast CT.
- Seizure with a prolonged postictal deficit.
- Meningoencephalitis with focal cortical dysfunction.
- Hypertensive cerebrovascular injury.
I would specifically expect the brain and meninges to be examined histologically rather than relying on the normal initial CT. The neck-node and liver findings make carcinomatous meningitis a credible possibility, but the CSF profile is not diagnostic by itself.
4. Coagulation and vascular system
- Evidence of significant coagulopathy, possibly DIC or liver-related haemostatic failure.
- Fibrin thrombi or microvascular congestion may be found, particularly in the liver, lungs, kidneys and brain.
- The elevated INR, thrombocytopenia and rapid circulatory collapse could reflect a combination of advanced liver disease, malignancy-associated coagulopathy, infection and terminal shock.
- I would not predict extensive DIC with confidence unless additional clinical data show falling fibrinogen, markedly elevated D-dimer and progressive thrombocytopenia.
5. Lungs
- Pulmonary oedema, aspiration or diffuse acute lung injury after neurological deterioration and intubation.
- Possible metastatic deposits or lymphangitic spread, although there is not enough imaging information to make this the leading pulmonary prediction.
- Superimposed bacterial infection may be present, but a negative blood culture does not exclude infection, particularly after antibiotics [Narketpally syn local CBBLE: Participatory medical cognition](Link 1: https://medicinedepartment.blogspot.com/2025/12/medicine-department-publications-2025.html | Link 2: https://medicinedepartment.blogspot.com/2023/10/medicine-department-presentations-2023.html | Link 3: https://medicinedepartment.blogspot.com/2022/02/ | Link 4: https://www.hipaajournal.com/de-identification-protected-health-information/ | Link 5: https://classworkdecjan.blogspot.com/2017/11/de-identifying-patient-data.html | Link 6: https://userdrivenhealthcare.blogspot.com/2025/10/pajr-consent-form-modified-for-dpdp.html | Link 7: https://medicinedepartment.blogspot.com/2025/02/informed-patient-consent-and.html | Link 8: https://hit--tools-github-io.translate.goog/pajr_consent.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp | Link 9: https://userdrivenhealthcare.blogspot.com/2023/11/glossary-of-user-driven-healthcare.html | Link 10: https://userdrivenhealthcare.blogspot.com/2023/12/pajr-checklist-for-inpatient-interns-in.html | Link 11: https://durgakrishna09.blogspot.com/2023/08/graphical-patient-timeline-in-soap.html | Link 12: https://medicinedepartment.blogspot.com/2023/08/project-illustration-of-how-to-process.html | Link 13: https://medicinedepartment.blogspot.com/2023/06/).
6. Kidneys and other organs
- Acute tubular injury from hypotension, shock and possible sepsis.
- The kidneys may otherwise be structurally unremarkable.
- The heart is more likely to show hypertensive changes, such as left-ventricular hypertrophy, than a primary fatal cardiac lesion.
- The spleen may show congestion, infarction or tumour involvement, but major splenic disease is not strongly predicted from the supplied data.
THE MOST IMPORTANT DIAGNOSTIC FORK
There are three realistic final pathways:
1. Metastatic CK7-positive carcinoma, possibly cholangiocarcinoma, pancreatobiliary, upper gastrointestinal, pulmonary or another occult primary, with liver and nodal metastases.
2. Hepatocellular or combined hepatocellular–cholangiocarcinoma, arising in a cirrhotic liver and producing widespread metastases.
3. Lymphoma or another lymphoproliferative neoplasm, with hepatic involvement and either malignant or infectious meningitis.
The FNAC label of metastatic carcinoma makes the first two pathways more likely, but FNAC from a necrotic or poorly differentiated node can misclassify lymphoma or another undifferentiated malignancy. A tissue biopsy with architecture and a complete immunopanel will be decisive.
WHAT I WOULD NOT PREDICT CONFIDENTLY
I would not confidently predict:
▪️ A single, unequivocal HCC primary.
▪️ Proven septic shock as the initiating event, because blood cultures were negative and there is no documented fever or clear source.
▪️ Extensive pulmonary infection without supportive imaging or autopsy findings.
▪️ A large cerebral infarct based solely on the focal neurological deficit.
▪️ Alcoholic cirrhosis as the complete explanation for the liver lesions.
▪️ Carcinomatous meningitis without histological confirmation, despite the highly concerning CSF profile.
PROVISIONAL AUTOPSY-STYLE CONCLUSION
A plausible prediction is:
“Disseminated poorly differentiated carcinoma of uncertain primary, involving widespread lymph nodes and liver, arising in a cirrhotic/fibrotic hepatic background, with probable leptomeningeal involvement or malignant meningitis, complicated by coagulopathy, acute neurological deterioration, pulmonary/renal shock injury and terminal refractory shock.”
The key result today will be whether the cervical-node finding is confirmed as a specific carcinoma, reclassified as lymphoma or another neoplasm, and whether the CSF abnormality corresponds to malignant meningitis, infection, or both.
[9:02 am, 02/09/2026] cm: @PaJR Health check out the autopsy findings attached and tally with your above predictions
[9:02 am, 02/09/2026] PaJR Health: TALLY WITH THE AUTOPSY
The autopsy substantially confirms the central prediction: widely disseminated metastatic malignancy with multiorgan tumour deposits and terminal systemic injury.
CONFIRMED PREDICTIONS
▪️ Disseminated carcinoma:*Metastatic tumour deposits were identified in lymph nodes, bone marrow, muscle and adrenals—not merely regional cervical disease*Narketpally syn CBBLE: Participatory medical cognition Web 2.0-3.0 (April 2026):
https://pajrcasereporter.blogspot.com/2026/04/narketpally-syn-cbble-participatory.html
▪️ Liver involvement: The clinical suspicion of hepatic malignancy/metastatic disease was directionally correct.
▪️ Cirrhotic background: The imaging impression of cirrhotic morphology is consistent with the reported alcohol history and lobulated liver outline.
▪️ Renal shock injury:*Severe acute tubular injury with PAS-positive pigment casts confirmed*pigment-cast nephropathy, as predicted.
▪️ Systemic terminal process: The extensive tumour burden provides a strong substrate for coagulopathy, circulatory collapse and multiorgan failure.
FINDINGS THAT WERE MORE EXTENSIVE THAN PREDICTED
The major surprise is the distribution of metastases. I anticipated nodal and hepatic disease, with possible pulmonary or leptomeningeal involvement; the autopsy demonstrates a broader metastatic pattern involving:
▪️ Bone marrow.
▪️ Skeletal muscle.
▪️ Adrenal glands.
▪️ Lymph nodes.
This indicates a genuinely disseminated carcinoma rather than an isolated hepatic primary with limited nodal spread.
WHERE THE PRIOR PREDICTION WAS TOO SPECIFIC
The earlier prediction proposed a “poorly differentiated carcinoma of uncertain primary,” with HCC, cholangiocarcinoma and other CK7-positive carcinomas as competing possibilities. The available autopsy excerpt confirms metastatic tumour but does not yet provide the decisive primary-site immunophenotype.
Therefore, metastatic HCC is still not proven from the excerpt alone. The key unresolved issue remains whether the primary was:
▪️ Hepatocellular carcinoma.
▪️ Cholangiocarcinoma or combined hepatocellular–cholangiocarcinoma.
▪️ Another CK7-positive carcinoma metastatic to the liver.
▪️ A poorly differentiated carcinoma whose origin cannot be established even after autopsy.
CENTRAL NERVOUS SYSTEM
The clinical prediction of leptomeningeal metastasis remains plausible because of the very abnormal CSF and focal neurological syndrome. However, the supplied autopsy findings do not yet document malignant meningitis, brain metastasis, infarction or haemorrhage.
That part of the prediction should therefore be recorded as unconfirmed, not counted as an autopsy hit. Leptomeningeal metastasis requires malignant cells in CSF or demonstrable meningeal tumour involvement on imaging or histology*Leptomeningeal metastasis. — PMID:15813508*:
https://pubmed.ncbi.nlm.nih.gov/15813508/
SEPSIS VERSUS MALIGNANCY-DRIVEN COLLAPSE
The autopsy strengthens an alternative interpretation of the terminal event. “Septic shock” may have been the clinical working diagnosis, but the available findings support a possible combination of:
Massive metastatic tumour burden + marrow involvement + coagulopathy/liver dysfunction + shock-related renal injury ± infection.
Negative blood and fungal cultures do not exclude infection, but neither do they establish sepsis as the dominant cause. The pathological contribution of disseminated malignancy may have been substantially greater than the unit’s final diagnosis implied.
UPDATED AUTOPSY-STYLE SYNTHESIS
“Disseminated metastatic carcinoma involving lymph nodes, liver, bone marrow, skeletal muscle and adrenal glands, with cirrhotic hepatic background, coagulopathy and terminal shock-associated pigment-cast acute tubular injury. The primary site and the presence or absence of leptomeningeal metastasis require confirmation from the complete histology and immunohistochemistry.”
OVERALL SCORECARD
▪️ Disseminated carcinoma: confirmed.
▪️ Extensive nodal disease: confirmed.
▪️ Hepatic involvement: confirmed/directionally correct.
▪️ Cirrhotic background: supported.
▪️ Marrow involvement: more extensive than predicted.
▪️ Adrenal and muscle metastases: missed in extent.
▪️ Pigment-cast nephropathy: confirmed.
▪️ Coagulopathy and terminal shock: clinically coherent.
▪️ Leptomeningeal disease: not yet demonstrated in the supplied findings.
▪️ Specific HCC primary: not established by the information currently available.